Advertisement

Indication and Results of Stereotactic Curietherapy with Iridium-192 and Iodine-125 for Non-resectable Tumours of the Hypothalamic Region

  • F. Mundinger
  • K. Weigel
Conference paper
Part of the Acta Neurochirurgica book series (NEUROCHIRURGICA, volume 33)

Abstract

Therapeutic approaches to tumours of the hypothalamic region vary primarily depending on the degree to which the tumour can be surgically resected. However, residual portions of the tumour following surgery or recurrent tumours present special problems. In the case of hypothalamic gliomas, severe clinical deficits, significant postoperative neurologic morbidity and mortality are expected after attempts at open resection. Therefore at many institutions nothing is done after the clinical or CT diagnosis of a hypothalamic process, or at most, “ut aliquid fiat”, external irradiation might be carried out. Today this mode of procedure is highly unsatisfying and the Situation calls for an effective therapy concept. Knowledge of the type of tumour and its grading is prerequisite for selecting the therapeutic procedure. CT- stereotactic biopsy is the most reliable and least dangerous method of obtaining this information1,4,6,7. Based on the findings from the intraoperative smear preparation, the form of therapy can be immediately decided upon. Interstitial curietherapy, for example, can be initiated right away2,5.

Keywords

Pituitary Adenoma Pilocytic Astrocytoma Open Resection Stereotactic Biopsy Hypothalamic Region 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Birg, W., Mundinger, F., Direct target point determination for stereotactic brain Operations from CT data and the calculation of setting parameters for polar-coordinate stereotactic devices. Appl. Neurophysiol. 45 (1982), 387— 395.PubMedGoogle Scholar
  2. 2.
    Mundinger, F., Treatment of brain tumors with radioisotopes. In: Progress of Neurological Surgery, Bd. I (Krayenbühl, H., Maspes, M., Sweet, Ch., eds.), pp.202–257. Basel: Karger. 1966.Google Scholar
  3. 3.
    Mundinger, F., The treatment of brain tumors with interstitially applied radioactive isotopes. In: Radionuclide Applications in Neurology and Neurosurgery (Wang, Y., Paoletti, P., eds.), pp. 199—265. Springfield, Ill.: Ch. C Thomas. 1970.Google Scholar
  4. 4.
    Mundinger, F., CT-Stereotactic biopsy of brain tumours. In: Tumours of the Central Nervous System in Infancy and Childhood (Voth, D., Gutjahr, P., Langmaid, C., eds.), pp. 234—246. Berlin-Heidelberg-New York: Springer. 1982.Google Scholar
  5. 5.
    Mundinger, F., Implantation of radioisotopes (Curietherapy). In: Stereotaxy of the Human Brain, 2nded. (Schaltenbrand, G., Walker, W., eds.), pp. 410–435. Stuttgart: Thieme. 1982.Google Scholar
  6. 6.
    Mundinger, F., Birg, W., Stereotactic brain surgery with the aid of computed tomography (CT-stereotaxy). In: Computerized Tomography, Brain Metabolism, Spinal Injuries (Driesen, W., Brock, M., Klinger, M., eds.), pp. 17–24. Advanc. Neurosurg. 10. Berlin-Heidelberg-New York: Springer. 1982.CrossRefGoogle Scholar
  7. 7.
    Mundinger, F., Metzel, E., Interstitial radioisotope therapy of intractable diencephalic tumors by the stereotaxie permanent implantation of Iridium-192, including bioptic control. Confin. neurol. 32 (1970), 195–202.PubMedCrossRefGoogle Scholar
  8. 8.
    Mundinger, F., Riechert, T., Hypophysentumoren — Hypophysektomie. Klinik-Therapie-Ergebnisse. Stuttgart: Thieme. 1967.Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • F. Mundinger
    • 1
  • K. Weigel
  1. 1.Abteilung Stereotaxie und NeuronuklearmedizinNeurochirurgische UniversitätsklinikFreiburg im BreisgauFederal Republic of Germany

Personalised recommendations